VASCEPA

Peak

icosapent ethyl

NDAORALCAPSULE

Approved

Jul 2012

Lifecycle

Peak

Competitive Pressure

0/100

Loss of Exclusivity

LOE Date

Jun 28, 2033

89 months away

Patent Expiry

Jun 28, 2033

Patent Records (5)

Patent #	Expiry	Type	Use Code
9700537	May 31, 2027		U-2707
9198892	Sep 25, 2027		U-2706
8546372	Feb 9, 2030		U-1287
12171738	Feb 9, 2030		U-4105
8518929	Feb 9, 2030		U-1287

Company

Turkey - Istanbul

External Resources

Full prescribing information

FDA approval history

Drug nomenclature & identifiers